- Home
- KTTA vs JWEL Comparison
KTTA vs JWEL Comparison
Compare KTTA & JWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- JWEL
- Stock Information
- Founded
- KTTA 2020
- JWEL 2012
- Country
- KTTA United States
- JWEL China
- Employees
- KTTA N/A
- JWEL N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- JWEL Other Consumer Services
- Sector
- KTTA Health Care
- JWEL Consumer Discretionary
- Exchange
- KTTA Nasdaq
- JWEL Nasdaq
- Market Cap
- KTTA 5.1M
- JWEL 5.2M
- IPO Year
- KTTA 2021
- JWEL 2021
- Fundamental
- Price
- KTTA $0.68
- JWEL $1.89
- Analyst Decision
- KTTA
- JWEL
- Analyst Count
- KTTA 0
- JWEL 0
- Target Price
- KTTA N/A
- JWEL N/A
- AVG Volume (30 Days)
- KTTA 119.6K
- JWEL 80.7K
- Earning Date
- KTTA 08-19-2025
- JWEL 08-19-2025
- Dividend Yield
- KTTA N/A
- JWEL N/A
- EPS Growth
- KTTA N/A
- JWEL N/A
- EPS
- KTTA N/A
- JWEL N/A
- Revenue
- KTTA N/A
- JWEL $132,981,531.00
- Revenue This Year
- KTTA N/A
- JWEL N/A
- Revenue Next Year
- KTTA N/A
- JWEL N/A
- P/E Ratio
- KTTA N/A
- JWEL N/A
- Revenue Growth
- KTTA N/A
- JWEL N/A
- 52 Week Low
- KTTA $0.65
- JWEL $1.18
- 52 Week High
- KTTA $7.50
- JWEL $3.71
- Technical
- Relative Strength Index (RSI)
- KTTA 38.79
- JWEL 40.79
- Support Level
- KTTA $0.67
- JWEL $1.65
- Resistance Level
- KTTA $0.79
- JWEL $2.40
- Average True Range (ATR)
- KTTA 0.04
- JWEL 0.16
- MACD
- KTTA 0.00
- JWEL -0.04
- Stochastic Oscillator
- KTTA 23.70
- JWEL 32.00
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About JWEL Jowell Global Ltd.
Jowell Global Ltd is a cosmetics, health, nutritional supplements, and household products e-commerce platform in China. The company offers its branded products to customers and also sells and distributes products from other companies on its platform. In addition, it allows third parties to open their stores on its platform for a service fee based on their sales revenues generated from their online stores and provides them with information about market needs, enabling them to manage their sales effort, as well as an effective platform to promote their brands. The company currently operates under four sales channels: Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing. Geographically, it generates all of its revenue from the PRC.